News

JinkoSolar Reports Impressive Q3 2024 Results For Stakeholders

JinkoSolar Reports Impressive Q3 2024 Results For Stakeholders

JinkoSolar's Strong Business Performance in Q3 2024

JinkoSolar Holding Co., Ltd. (NYSE: JKS), a prominent player in the solar module manufacturing sector, has unveiled its unaudited financial results for the third quarter. Highlighting remarkable milestones, the company has solidified its leadership in the industry.

Key Operational Achievements

In Q3 2024, JinkoSolar leveraged its competitive edge through innovations in N-type TOPCon technology and expanded its global marketing efforts. These strategies resulted in the company's module shipments leading the industry during the quarter and throughout the year.

Record Shipment Highlights

Notably, JinkoSolar became the first in its category to surpass 280 GW of delivered solar modules by the third quarter's end. Approximately 90% of these shipments comprised N-type modules, showcasing the sustained demand and production capability for these advanced technologies.

Production Efficiency

The production efficiency of N-type TOPCon cells reached a commendable 26.2% at the close of the quarter, reflecting JinkoSolar's commitment to innovation and quality improvement in product manufacture.

Financial Performance Overview

During this quarter, JinkoSolar recorded total shipments of 25,910 MW, which included 23,838 MW for solar modules and 2,072 MW for cells and wafers. This marked a 2.3% quarter-over-quarter increase and a substantial 14.7% increase compared to the previous year's performance.

Revenue Summary

Total revenues for Q3 stood at RMB24.51 billion (approximately US$3.49 billion), up 1.9% from the previous quarter but down 23% from the third quarter of the prior year. This decline was primarily due to falling average selling prices in the competitive market.

Profit and Earnings Details

The gross profit in Q3 was reported at RMB3.86 billion (approximately US$549.4 million), which marked a 44% increase sequentially but reflected a decrease of 37.1% year-over-year. The gross margin at 15.7% displayed notable improvement compared to Q2 2024, even though it was slightly below the 19.3% achieved in Q3 2023.

Market Dynamics and Future Outlook

CEO Xiande Li shared insights on the operational landscape, highlighting the continuing imbalance between supply and demand that led to a drop in prices throughout the industry. However, he commended the company for achieving stable price levels and an increase in shipments to the U.S. market. JinkoSolar remains dedicated to refining its integrated cost and enhancing the production process through technological advancements.

Anticipating Industry Changes

In light of recent market volatility, measures were initiated by the China Photovoltaic Industry Association to encourage pricing discipline among manufacturers, targeting a healthier bidding environment. JinkoSolar anticipates that these changes will aid in stabilizing prices and streamlining operations across the sector.

Strategic Vision Going Forward

With an ambitious goal, JinkoSolar aims to maintain their high module shipments levels between 90 GW to 100 GW by the close of the year. The company will focus on strengthening its asset structure and financial efficiency to navigate potential industry challenges.

Looking Ahead: Q4 and Beyond

The outlook for Q4 is promising, with expectations of module shipments ranging between 22.3 GW to 32.3 GW. Furthermore, JinkoSolar expects to reach an annual production capacity of 120 GW for mono wafers, 95 GW for solar cells, and 130 GW for solar modules by year-end.

Recent Developments and Innovations

Significant events also marked this quarter, including the completion of a large-scale delivery of over 1,000 PV modules aimed at supporting community recovery initiatives in the aftermath of regional disasters. The company was also awarded recognition as a top performer in the Renewable Energy Testing Center's PV Module Index Report for five consecutive years.

Conference Call and Updates

Management has planned an earnings conference call to discuss these results further, where stakeholders can engage with executive insights on JinkoSolar's business trajectory.

Frequently Asked Questions

What are JinkoSolar's key successes highlighted in Q3 2024?

JinkoSolar achieved industry-leading module shipments, significant operational milestones, and remarkable production efficiencies.

What financial figures did JinkoSolar report for Q3 2024?

The company reported RMB24.51 billion in total revenue and RMB3.86 billion in gross profit during the quarter.

How does JinkoSolar plan to address market fluctuations?

JinkoSolar is focused on maintaining pricing stability, optimizing operational efficiency, and adopting technologies for modern production needs.

What is the outlook for JinkoSolar's shipments in Q4 2024?

The company anticipates module shipments to fall between 22.3 GW and 32.3 GW for Q4.

What initiatives did JinkoSolar undertake for sustainability recently?

JinkoSolar has been involved in community recovery through donations of solar modules and has focused on enhancing sustainable practices in operations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 127

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 184

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 342

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 342

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Genmab's Ongoing Share Buy-back Program Details and Impact

Updated Category News Views 119

Introduction to the Share Buy-back Program In a recent announcement, Genmab A/S (NASDAQ: GMAB) revealed that it has initiated an ambitious share buy-back program. This initiative aims to repurchase up to 2.2 million shares, which is a strategic step not just to reduce capital but also to fulfill commitments under the Restricted Stock Unit program. The company anticipates...

Continue Reading
Allego Strengthens Leadership with New Innovative CTO

Updated Category News Views 159

Allego Appoints Holger Riemenschneider as Chief Technology Officer Allego N.V. (NASDAQ: ALGO) has recently appointed Holger Riemenschneider as its Chief Technology Officer. This move is a significant step for the company, which has rapidly established itself as a leading name in the electric vehicle (EV) charging industry. With Holger on board, Allego is looking to...

Continue Reading
Exploring the Growth Drivers of Semiconductor Fabrication Software

Updated Category News Views 167

Understanding the Semiconductor Fabrication Software Market The Semiconductor Fabrication Software market is on the brink of significant transformation, with projections indicating a remarkable growth of approximately USD 984.91 million from 2024 to 2028. This growth is primarily fueled by the rising complexity of semiconductor designs in conjunction with the impact of...

Continue Reading
Ohmyhome Prepares to Share Exciting Q3 2024 Growth Insights

Updated Category News Views 45

Ohmyhome Set to Unveil Q3 2024 Growth Insights As a leading property technology platform, Ohmyhome Ltd. (NASDAQ: OMH) has established itself as a prominent player in the real estate market. The company specializes in offering comprehensive solutions ranging from brokerage, renovation, and management services for properties in the region. As consumers increasingly look for...

Continue Reading
Eli Lilly Prepares for Major Breast Cancer Data Presentation

Updated Category News Views 220

Introduction to Eli Lilly's Breast Cancer Initiatives At the upcoming San Antonio Breast Cancer Symposium (SABCS), Eli Lilly and Company (NYSE: LLY) is set to unveil groundbreaking data that enhances its portfolio in breast oncology. The symposium, running from December 9 to 12, serves as a platform for Lilly to highlight advancements in treatments for hormone...

Continue Reading